Final results of a randomized phase II study of perifosine in combination with capecitabine (P-CAP) versus placebo plus capecitabine (CAP) in patients (pts) with second- or third-line metastatic colorectal cancer (mCRC).

2010 ◽  
Vol 28 (15_suppl) ◽  
pp. 3531-3531 ◽  
Author(s):  
D. A. Richards ◽  
J. J. Nemunaitis ◽  
S. J. Vukelja ◽  
C. T. Hagenstad ◽  
L. T. Campos ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Randomized Phase Ii ◽  
Third Line

5-Fluorouracil Administered as a 48-Hour Chronomodulated Infusion in Combination with Leucovorin and Cisplatin: A Randomized Phase II Study in Metastatic Colorectal Cancer

Oncology ◽  
2001 ◽  
Vol 61 (1) ◽  
pp. 28-35 ◽  
Author(s):  
Alfredo Falcone ◽  
Giacomo Allegrini ◽  
Gianluca Masi ◽  
Monica Lencioni ◽  
Elisabetta Pfanner ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Randomized Phase Ii

Persistent prevention of CIPN using calmangafodipir (PledOx): Results from a placebo-controlled randomized phase II study (PLIANT) in patients with metastatic colorectal cancer (mCRC).

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 10018-10018 ◽  
Author(s):  
Bengt Glimelius ◽  
Nebojsa Manojlovic ◽  
Per Pfeiffer ◽  
Baadur Mosidze ◽  
Galina Petrova Kurteva ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Randomized Phase Ii

A Randomized Phase II Study of FOLFOX6/Bevacizumab With or Without Pelareorep in Patients With Metastatic Colorectal Cancer: IND.210, a Canadian Cancer Trials Group Trial

2018 ◽  
Vol 17 (3) ◽  
pp. 231-239.e7 ◽  
Author(s):  
Derek J. Jonker ◽  
Patricia A. Tang ◽  
Hagen Kennecke ◽  
Stephen A. Welch ◽  
M. Christine Cripps ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Randomized Phase Ii ◽  
Cancer Trials ◽  
Group Trial
Sign in / Sign up

Export Citation Format

Share Document